|
Mark Atkinson, Ph.D. (born March 27, 1961) is a medical researcher best known for his contributions to research seeking to predict, prevent, and cure type 1 diabetes. He is the author of over 350 publications and is one of the world’s most cited diabetes researchers. Atkinson currently conducts research at the University of Florida College of Medicine, where he is Director for the Diabetes Institute at UF Health. He also is the Executive Director of the Network for Pancreatic Organ donors with Diabetes (nPOD).〔(【引用サイトリンク】url=http://diabetes.ufl.edu/research/type-1-diabetes/research-2/atkinson-lab/ )〕 Atkinson has also been widely cited for his humanitarian contributions, particularly his efforts to improve diabetes care, management, and access to medications and supplies in developing nations. ==Background and education== Mark Atkinson was born and raised in southeastern Michigan. He attended the University of Michigan – Dearborn where he received a B.S. in microbiology in 1983. Atkinson next received a Ph.D. from the Department of Pathology at the University of Florida in 1987.〔(【引用サイトリンク】url=http://pathology.ufl.edu/faculty/experimental-pathology/mark-a-atkinson/ )〕 While at the University of Florida, Atkinson studied under diabetes researcher Dr. Noel Maclaren, who became his mentor and fostered Atkinson’s interest in type 1 diabetes research. His work with Maclaren led Atkinson to develop his three goals of determining what causes type 1 diabetes, identifying a means to predict T1D, and developing a way to prevent and cure the disease. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Mark Atkinson (scientist)」の詳細全文を読む スポンサード リンク
|